We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Abbott Lab, SAP SE, Freeport-McMoRan, Kraft Heinz and American International Group
Read MoreHide Full Article
For Immediate Release
Chicago, IL – February 19, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Abbott Laboratories (ABT - Free Report) , SAP SE (SAP - Free Report) , Freeport-McMoRan Inc. (FCX - Free Report) , The Kraft Heinz Company (KHC - Free Report) and American International Group, Inc. (AIG - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Analyst Reports for Abbott, SAP and Freeport McMoRan
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, SAP SE and Freeport-McMoRan. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Abbott shares have outperformed the Zacks Medical Products industry in the year to date period (+16.2% vs. +8.8%). The Zacks analyst believes that the company has been seeing improvements in testing and procedure volumes across its hospital-based businesses.
At the same time, its consumer-facing businesses like diabetes care, nutrition and established pharmaceuticals (EPD), are catching up pace. In Adult Nutrition, the company reported strong double-digit growth on robust sales of Ensure and Glucerna.
In 2020, the company received U.S. approval of Freestyle Libre 2 and CE Mark for Libre 3 and Libre Sense Glucose Sport. Yet, Abbott’s performance was disappointing especially in Pediatric Nutrition, Cardiovascular and Neuromodulation.
Shares of SAP have lost -21.7% in the last six months against the Zacks Computer Software industry’s gain of +14.9%. The Zacks analyst believes that SAP is well-positioned to benefit from robust uptake of S/4HANA, and SuccessFactors Employee Central solutions.
Momentum witnessed by Ariba and Fieldglass solutions is also noteworthy. SAP's alliances with IBM, Microsoft, Accenture and Verizon favor business prospects. The company is also well-poised to gain from healthy contribution from Sapphire Ventures.
Further, high demand for e-commerce, digital supply chain, Qualtrics and cloud platform solutions, augurs well over the longer haul. Nevertheless, soft uptake of software licenses and support offerings remains a headwind. Rise in investments to enhance cloud-based offerings are likely to weigh on margins in near term.
Freeport-McMoRan’s shares have gained +61.8% over the past three months against the Zacks Mining – Non Ferrous industry’s rise of +44.1%. The Zacks analyst expects the company to gain from progress in exploration activities that will boost its production capacity.
It is also well-positioned to benefit from automotive electrification. Furthermore, higher copper prices are also expected to support its margins. Freeport's efforts to reduce debt are also encouraging.
However, it faces operational challenges in certain mines. Declining sales volumes is another concern. Moreover, lower volumes across North and South America have led to higher unit costs across these operations.
Other noteworthy reports we are featuring today include Kraft Heinz and American International Group.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights: Abbott Lab, SAP SE, Freeport-McMoRan, Kraft Heinz and American International Group
For Immediate Release
Chicago, IL – February 19, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Abbott Laboratories (ABT - Free Report) , SAP SE (SAP - Free Report) , Freeport-McMoRan Inc. (FCX - Free Report) , The Kraft Heinz Company (KHC - Free Report) and American International Group, Inc. (AIG - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Analyst Reports for Abbott, SAP and Freeport McMoRan
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, SAP SE and Freeport-McMoRan. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Abbott shares have outperformed the Zacks Medical Products industry in the year to date period (+16.2% vs. +8.8%). The Zacks analyst believes that the company has been seeing improvements in testing and procedure volumes across its hospital-based businesses.
At the same time, its consumer-facing businesses like diabetes care, nutrition and established pharmaceuticals (EPD), are catching up pace. In Adult Nutrition, the company reported strong double-digit growth on robust sales of Ensure and Glucerna.
In 2020, the company received U.S. approval of Freestyle Libre 2 and CE Mark for Libre 3 and Libre Sense Glucose Sport. Yet, Abbott’s performance was disappointing especially in Pediatric Nutrition, Cardiovascular and Neuromodulation.
(You can read the full research report on Abbott here >>>)
Shares of SAP have lost -21.7% in the last six months against the Zacks Computer Software industry’s gain of +14.9%. The Zacks analyst believes that SAP is well-positioned to benefit from robust uptake of S/4HANA, and SuccessFactors Employee Central solutions.
Momentum witnessed by Ariba and Fieldglass solutions is also noteworthy. SAP's alliances with IBM, Microsoft, Accenture and Verizon favor business prospects. The company is also well-poised to gain from healthy contribution from Sapphire Ventures.
Further, high demand for e-commerce, digital supply chain, Qualtrics and cloud platform solutions, augurs well over the longer haul. Nevertheless, soft uptake of software licenses and support offerings remains a headwind. Rise in investments to enhance cloud-based offerings are likely to weigh on margins in near term.
(You can read the full research report on SAP here >>>)
Freeport-McMoRan’s shares have gained +61.8% over the past three months against the Zacks Mining – Non Ferrous industry’s rise of +44.1%. The Zacks analyst expects the company to gain from progress in exploration activities that will boost its production capacity.
It is also well-positioned to benefit from automotive electrification. Furthermore, higher copper prices are also expected to support its margins. Freeport's efforts to reduce debt are also encouraging.
However, it faces operational challenges in certain mines. Declining sales volumes is another concern. Moreover, lower volumes across North and South America have led to higher unit costs across these operations.
(You can read the full research report on Freeport-McMoRan here >>>)
Other noteworthy reports we are featuring today include Kraft Heinz and American International Group.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.